✦ LIBER ✦

The preclinical detection of Parkinson's disease: Ready for prime time?

✍ Scribed by Matthew B. Stern

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 56 KB
Volume: 56
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.20180

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of apolipoprotein E genotype for

The use of apolipoprotein E genotype for preclinical detection of risk's group for Alzheimer's disease

✍ Oliveira, J.R. Mendes; Filho, J.L. Lima; Shimokomaki, C.M.; Okuma, M.; Passos-Bu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

Timing of treatment initiation in Parkin

Timing of treatment initiation in Parkinson's disease: A need for reappraisal?

✍ Anthony H. V. Schapira; Jose Obeso 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

Critical evaluation of the Braak staging

Critical evaluation of the Braak staging scheme for Parkinson's disease

✍ Kurt A. Jellinger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Quetiapine for the treatment of drug-ind

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 1 views

A critical evaluation of the Braak stagi

A critical evaluation of the Braak staging scheme for Parkinson's disease

✍ Robert E. Burke; William T. Dauer; Jean Paul G. Vonsattel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

## Abstract Braak and colleagues have proposed that, within the central nervous system, Parkinson's disease (PD) begins as a synucleinopathy in nondopaminergic structures of the lower brainstem or in the olfactory bulb. The brainstem synucleinopathy is postulated to progress rostrally to affect the

Rapid detection of Parkinson's disease b

Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters

✍ Alan J. Fischman; Ali A. Bonab; John W. Babich; E. Prather Palmer; Nathaniel M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 1 views

Increasing evidence indicates that dopamine (DA) transporter density declines in Parkinson's disease (PD). 2␤-Carbomethoxy-3␤-(4-fluorophenyl)-n-(1-iodoprop-1-en-3-yl) nortropane (IACFT, Altropane) is a cocaine analog with high affinity and selectivity for dopamine transporter (DAT) sites in the str